1. Figure 1 Flowchart data extraction and cleaning process from the Global Price Reporting Mechanism in 2008 for the countries studied.
From: Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America
Health Policy Plan. 2012;27(8): doi: /heapol/czs011
Health Policy Plan | Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine © The Author 2012; all rights reserved.

2. Figure 2 Patient ratios for first-line ARV therapy stavudine+lamivudine+nevirapine at various benchmark prices. A patient ratio of 1 means that the procurement price is the same as the benchmark price. A ratio of <1 means that the procurement price is below the benchmark and >1 means that the procurement price is above the benchmark price. LDMC = Lowest direct manufacturing cost; HDMC = highest direct manufacturing cost; LRGP = lowest regional generic price; LRIP = lowest regional innovator price; MLMTP = Median lower-middle-income country transaction price.
From: Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America
Health Policy Plan. 2012;27(8): doi: /heapol/czs011
Health Policy Plan | Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine © The Author 2012; all rights reserved.

3. Figure 3 Patient ratios of first-line ARV therapy zidovudine+lamivudine+efavirenz at various benchmark prices. A patient ratio of 1 means that the procurement price is the same as the benchmark price. A ratio of <1 means that the procurement price is below the benchmark and >1 means that the procurement price is above the benchmark price. LDMC = Lowest direct manufacturing cost; HDMC = highest direct manufacturing cost; LRGP = lowest regional generic price; LRIP = lowest regional innovator price; MLMTP = Median lower-middle-income country transaction price.
From: Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America
Health Policy Plan. 2012;27(8): doi: /heapol/czs011
Health Policy Plan | Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine © The Author 2012; all rights reserved.

4. Figure 4 Patient ratios of second-line therapy abacavir+didanosine+lopinavir/ritonavir at various benchmark prices. A patient ratio of 1 means that the procurement price is the same as the benchmark price. A ratio of <1 means that the procurement price is below the benchmark and >1 means that the procurement price is above the benchmark price. LDMC = Lowest direct manufacturing cost; HDMC = highest direct manufacturing cost; LRGP = lowest regional generic price; LRIP = lowest regional innovator price; MLMTP = Median lower-middle-income country transaction price.
From: Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America
Health Policy Plan. 2012;27(8): doi: /heapol/czs011
Health Policy Plan | Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine © The Author 2012; all rights reserved.

5. Figure 5 Patient ratios of second-line therapy didanosine+lamivudine+lopinavir/ritonavir at various benchmark prices. A patient ratio of 1 means that the procurement price is the same as the benchmark price. A ratio of <1 means that the procurement price is below the benchmark and >1 means that the procurement price is above the benchmark price. LDMC = Lowest direct manufacturing cost; HDMC = highest direct manufacturing cost; LRGP = lowest regional generic price; LRIP = lowest regional innovator price; MLMTP = Median lower-middle-income country transaction price.
From: Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America
Health Policy Plan. 2012;27(8): doi: /heapol/czs011
Health Policy Plan | Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine © The Author 2012; all rights reserved.